Long-term Effectiveness, Safety, and Performance of the Evoke Closed-Loop SCS System to Treat Patients With Chronic Pain of the Trunk and/or Limbs
Active, not recruitingNCT04627974
View the official record on ClinicalTrials.gov Recruiting status changes often. Contact the study team listed on ClinicalTrials.gov, and talk to your doctor before joining a study.
This study has no listed site in Canada in this snapshot. It is included as part of the worldwide chronic pain corpus.
Brief summary (from the registry)
The objective of this multicountry, multicentre, prospective study is to evaluate the long-term clinical effectiveness, safety, and performance of the Evoke System in the treatment of chronic pain of the trunk and/or limbs in a real-world population.
Study details
- Official title
- A Prospective Study to Evaluate the Long-term Effectiveness, Safety, and Performance of the Saluda Medical's EvokeTM Closed-Loop Spinal Cord Stimulation System to Treat Patients With Chronic Pain of the Trunk and/or Limbs
- Conditions
- Interventions
- Sponsor
- Saluda Medical Pty Ltd
- Start date
- 2020-08-05
- Primary completion
- 2023-04-03
- Sex
- All
- Results posted
- No results posted in this snapshot
- Countries
- Belgium, Germany, Netherlands, United Kingdom
- Total sites listed
- 8
Eligibility criteria
Show eligibility criteria (verbatim from the registry)
Inclusion Criteria: * Eligible for therapy according to the Evoke System indications for use statement and labelling requirements * Willing and capable of giving informed consent and able to comply with study-related requirements, procedures, and visits * Baseline VAS pain rating ≥60 mm in the primary area of pain Exclusion Criteria: * No further exclusion criteria
Source: ClinicalTrials.gov (US National Library of Medicine), snapshot October 2026. Check the registry for current recruiting status. Record: https://clinicaltrials.gov/study/NCT04627974